{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:06:54Z","timestamp":1792076814794,"version":"4.4.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PD\/BD\/128402\/2017"],"award-info":[{"award-number":["PD\/BD\/128402\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.virol.2022.11.001","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T08:11:12Z","timestamp":1668759072000},"page":"45-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Exploring new antiviral targets for influenza and COVID-19: Mapping promising hot spots in viral RNA polymerases"],"prefix":"10.1016","volume":"578","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3466-7239","authenticated-orcid":false,"given":"In\u00eas","family":"Figueiredo-Nunes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Trigueiro-Louro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0138-0944","authenticated-orcid":false,"given":"Helena","family":"Rebelo-de-Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.virol.2022.11.001_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00487-17","article-title":"Understanding the mechanism of the broad-spectrum antiviral activity of favipiravir (T-705): key role of the F1 motif of the viral polymerase","volume":"91","author":"Abdelnabi","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2022.11.001_bib2","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/s41559-021-01514-z","article-title":"The limits of SARS-CoV-2 predictability","volume":"5","author":"Baker","year":"2021","journal-title":"Nat Ecol Evol"},{"issue":"1","key":"10.1016\/j.virol.2022.11.001_bib3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res [Internet]"},{"issue":"6604 Suppl. l","key":"10.1016\/j.virol.2022.11.001_bib4","first-page":"23","article-title":"Structure-based drug design","volume":"384","author":"Blundell","year":"1996","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.virol.2022.11.001_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12967-020-02355-3","article-title":"SARS-CoV-2 RNA polymerase as target for antiviral therapy","volume":"18","author":"Buonaguro","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.virol.2022.11.001_bib6","series-title":"08; 1010 Sherbooke St. West, Suite #910","year":"2013"},{"key":"10.1016\/j.virol.2022.11.001_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-1-4614-0980-9_12","article-title":"Viral polymerases","volume":"726","author":"Choi","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"issue":"9","key":"10.1016\/j.virol.2022.11.001_bib8","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1099\/vir.0.011270-0","article-title":"Large-scale analysis of influenza A virus sequences reveals potential drug target sites of non-structural proteins","volume":"90","author":"Darapaneni","year":"2009","journal-title":"J Gen Virol [Internet]"},{"issue":"13","key":"10.1016\/j.virol.2022.11.001_bib9","doi-asserted-by":"crossref","first-page":"8669","DOI":"10.1128\/JVI.79.13.8669-8674.2005","article-title":"In vitro assembly of PB2 with a PB1-PA dimer supports a new model of assembly of influenza A virus polymerase subunits into a functional trimeric complex","volume":"79","author":"Deng","year":"2005","journal-title":"J. Virol."},{"issue":"24","key":"10.1016\/j.virol.2022.11.001_bib10","doi-asserted-by":"crossref","first-page":"11911","DOI":"10.1128\/JVI.01565-06","article-title":"Role of ran binding protein 5 in nuclear import and assembly of the influenza virus RNA polymerase complex","volume":"80","author":"Deng","year":"2006","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2022.11.001_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/gch2.1018","article-title":"Data, disease and diplomacy: GISAID's innovative contribution to global health","volume":"1","author":"Elbe","year":"2017","journal-title":"Glob Challenges"},{"issue":"7773","key":"10.1016\/j.virol.2022.11.001_bib12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41586-019-1530-7","article-title":"Structures of influenza A virus RNA polymerase offer insight into viral genome replication","volume":"573","author":"Fan","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.virol.2022.11.001_bib13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4149\/av_2013_02_113","article-title":"The RNA polymerase of influenza a virus: mechanisms of viral transcription and replication","volume":"57","author":"Fodor","year":"2013","journal-title":"Acta Virol."},{"issue":"17","key":"10.1016\/j.virol.2022.11.001_bib14","doi-asserted-by":"crossref","first-page":"9144","DOI":"10.1128\/JVI.78.17.9144-9153.2004","article-title":"The PA subunit is required for efficient nuclear accumulation of the PB1 subunit of the influenza A virus RNA polymerase complex","volume":"78","author":"Fodor","year":"2004","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2022.11.001_bib15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antivir. Res."},{"issue":"2","key":"10.1016\/j.virol.2022.11.001_bib16","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antivir. Res."},{"issue":"6492","key":"10.1016\/j.virol.2022.11.001_bib17","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1126\/science.abb7498","article-title":"Structure of the RNA-dependent RNA polymerase from COVID-19 virus","volume":"368","author":"Gao","year":"2020","journal-title":"Science"},{"issue":"45","key":"10.1016\/j.virol.2022.11.001_bib18","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1073\/pnas.1811345115","article-title":"The mechanism of resistance to favipiravir in influenza","volume":"115","author":"Goldhill","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.virol.2022.11.001_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100770","article-title":"Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template","volume":"297","author":"Gordon","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"23\u201324","key":"10.1016\/j.virol.2022.11.001_bib20","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S1359-6446(05)03624-X","article-title":"Predicting protein druggability","volume":"10","author":"Hajduk","year":"2005","journal-title":"Drug Discov. Today"},{"issue":"D1","key":"10.1016\/j.virol.2022.11.001_bib21","doi-asserted-by":"crossref","first-page":"D482","DOI":"10.1093\/nar\/gkw1065","article-title":"Virus Variation Resource-improved response to emergent viral outbreaks","volume":"45","author":"Hatcher","year":"2017","journal-title":"Nucleic Acids Res [Internet]"},{"issue":"2","key":"10.1016\/j.virol.2022.11.001_bib22","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/QCO.0000000000000532","article-title":"Influenza virus polymerase inhibitors in clinical development","volume":"32","author":"Hayden","year":"2019","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"7819","key":"10.1016\/j.virol.2022.11.001_bib23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41586-020-2368-8","article-title":"Structure of replicating SARS-CoV-2 polymerase","volume":"584","author":"Hillen","year":"2020","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.virol.2022.11.001_bib24","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd892","article-title":"The druggable genome","volume":"1","author":"Hopkins","year":"2002","journal-title":"Nat Rev Drug Discov [Internet]"},{"issue":"W1","key":"10.1016\/j.virol.2022.11.001_bib25","doi-asserted-by":"crossref","first-page":"W436","DOI":"10.1093\/nar\/gkv462","article-title":"PockDrug-Server: a new web server for predicting pocket druggability on holo and apo proteins","volume":"43","author":"Hussein","year":"2015","journal-title":"Nucleic Acids Res [Internet]"},{"issue":"Pt 8","key":"10.1016\/j.virol.2022.11.001_bib26","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1099\/vir.0.032813-0","article-title":"Characterization of the interaction between the influenza A virus polymerase subunit PB1 and the host nuclear import factor Ran-binding protein 5","volume":"92","author":"Hutchinson","year":"2011","journal-title":"J. Gen. Virol."},{"issue":"9","key":"10.1016\/j.virol.2022.11.001_bib27","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41594-021-00651-0","article-title":"Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis","volume":"28","author":"Kabinger","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"14","key":"10.1016\/j.virol.2022.11.001_bib28","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1093\/nar\/gkf436","article-title":"MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform","volume":"30","author":"Katoh","year":"2002","journal-title":"Nucleic Acids Res [Internet]"},{"issue":"1","key":"10.1016\/j.virol.2022.11.001_bib29","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1038\/s41467-019-10280-3","article-title":"Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors","volume":"10","author":"Kirchdoerfer","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2022.11.001_bib30","first-page":"64","article-title":"Development of anti-viral agents using molecular modeling and virtual screening techniques","volume":"11","author":"Kirchmair","year":"2011","journal-title":"Infect. Disord.: Drug Targets"},{"issue":"3\u20134","key":"10.1016\/j.virol.2022.11.001_bib31","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/BF01718315","article-title":"Influenza virus PB1 protein is the minimal and essential subunit of RNA polymerase","volume":"141","author":"Kobayashi","year":"1996","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virol.2022.11.001_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-021-03667-0","article-title":"Merck's COVID pill loses its lustre: what that means for the pandemic","author":"Kozlov","year":"2021","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.virol.2022.11.001_bib33","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/molbev\/msy096","article-title":"Mega X: molecular evolutionary genetics analysis across computing platforms","volume":"35","author":"Kumar","year":"2018","journal-title":"Mol. Biol. Evol."},{"issue":"2","key":"10.1016\/j.virol.2022.11.001_bib34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/vaccines6020028","article-title":"Immune history and influenza vaccine effectiveness","volume":"6","author":"Lewnard","year":"2018","journal-title":"Vaccines"},{"issue":"6","key":"10.1016\/j.virol.2022.11.001_bib35","first-page":"745","article-title":"Protein sequence alignments: a strategy for the hierarchical analysis of residue conservation","volume":"9","author":"Livingstone","year":"1993","journal-title":"Comput Appl Biosci"},{"issue":"5737","key":"10.1016\/j.virol.2022.11.001_bib36","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1126\/science.1115717","article-title":"Containing pandemic influenza at the source","volume":"309","author":"Longini","year":"2005","journal-title":"Science"},{"issue":"Suppl. 4","key":"10.1016\/j.virol.2022.11.001_bib37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0213-005X(12)70105-2","article-title":"Antiviral treatment and vaccination for influenza A(H1N1)pdm09 virus: lessons learned from the pandemic","volume":"30","author":"L\u00f3pez-Medrano","year":"2012","journal-title":"Enferm. Infecc. Microbiol. Cl\u00edn."},{"issue":"W1","key":"10.1016\/j.virol.2022.11.001_bib38","doi-asserted-by":"crossref","first-page":"W636","DOI":"10.1093\/nar\/gkz268","article-title":"The EMBL-EBI search and sequence analysis tools APIs in 2019","volume":"47","author":"Madeira","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2022.11.001_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198070","article-title":"COVID-19: review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking","volume":"286","author":"Magro","year":"2020","journal-title":"Virus Res."},{"issue":"1\u20133","key":"10.1016\/j.virol.2022.11.001_bib40","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejphar.2009.06.065","article-title":"Rational drug design","volume":"625","author":"Mandal","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.virol.2022.11.001_bib41","author":"Medicines and Healthcare products Regulatory Agency"},{"key":"10.1016\/j.virol.2022.11.001_bib42","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.coph.2016.08.003","article-title":"Antiviral therapies on the horizon for influenza","volume":"30","author":"Naesens","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"issue":"21","key":"10.1016\/j.virol.2022.11.001_bib44","volume":"10","author":"Naydenova","year":"2020","journal-title":"Russo bioRxiv"},{"key":"10.1016\/j.virol.2022.11.001_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117883","article-title":"Potential therapeutic targets for combating SARS-CoV-2: drug repurposing, clinical trials and recent advancements","volume":"256","author":"Pandey","year":"2020","journal-title":"Life Sci."},{"issue":"11","key":"10.1016\/j.virol.2022.11.001_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107774","article-title":"Structural and biochemical characterization of the nsp12-nsp7-nsp8 core polymerase complex from SARS-CoV-2","volume":"31","author":"Peng","year":"2020","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.virol.2022.11.001_bib47","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/infdis\/jis265","article-title":"Combination antiviral therapy for influenza: predictions from modeling of human infections","volume":"205","author":"Perelson","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2022.11.001_bib48","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.virusres.2017.01.013","article-title":"Structural insights into RNA synthesis by the influenza virus transcription-replication machine","volume":"234","author":"Pflug","year":"2017","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2022.11.001_bib49","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkr859","article-title":"ViPR: an open bioinformatics database and analysis resource for virology research","volume":"vol. 40","author":"Pickett","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.virol.2022.11.001_bib50","author":"Prioritizing"},{"issue":"Issue 1","key":"10.1016\/j.virol.2022.11.001_bib51","article-title":"Structural basis of SARS-CoV-2 polymerase inhibition by favipiravir","volume":"2","author":"Qi","year":"2021","journal-title":"Innovation"},{"key":"10.1016\/j.virol.2022.11.001_bib52","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.3390\/microorganisms8101610","article-title":"Detailed molecular interactions of favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and influenza virus polymerases in silico","volume":"8","author":"Sada","year":"2020","journal-title":"Microorganisms"},{"issue":"D1","key":"10.1016\/j.virol.2022.11.001_bib53","doi-asserted-by":"crossref","first-page":"D41","DOI":"10.1093\/nar\/gkx1094","volume":"46","author":"Sayers","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2022.11.001_bib54","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/prot.10365","article-title":"Conserved residue clustering and protein structure prediction","volume":"52","author":"Schueler-Furman","year":"2003","journal-title":"Proteins"},{"issue":"541","key":"10.1016\/j.virol.2022.11.001_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb5883","article-title":"An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice","volume":"12","author":"Sheahan","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"13","key":"10.1016\/j.virol.2022.11.001_bib56","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2807\/1560-7917.ES.2017.22.13.30494","article-title":"GISAID: global initiative on sharing all influenza data \u2013 from vision to reality","volume":"22","author":"Shu","year":"2017","journal-title":"Eurosurveillance"},{"issue":"9","key":"10.1016\/j.virol.2022.11.001_bib57","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2217\/fvl.14.66","article-title":"The RNA-dependent RNA polymerase of the influenza A virus","volume":"9","author":"Stubbs","year":"2014","journal-title":"Future Virol."},{"issue":"12","key":"10.1016\/j.virol.2022.11.001_bib58","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/emboj.2009.138","article-title":"Structural insight into the essential PB1-PB2 subunit contact of the influenza virus RNA polymerase","volume":"28","author":"Sugiyama","year":"2009","journal-title":"EMBO J."},{"key":"10.1016\/j.virol.2022.11.001_bib59","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrmicro.2016.87","article-title":"Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis","volume":"14","author":"te Velthuis","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virol.2022.11.001_bib60","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.virol.2019.04.009","article-title":"To hit or not to hit: large-scale sequence analysis and structure characterization of influenza A NS1 unlocks new antiviral target potential","volume":"535","author":"Trigueiro-Louro","year":"2019","journal-title":"Virology"},{"key":"10.1016\/j.virol.2022.11.001_bib61","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.csbj.2020.07.017","article-title":"Unlocking COVID therapeutic targets: a structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike","volume":"18","author":"Trigueiro-Louro","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.virol.2022.11.001_bib62","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.virol.2021.11.001","article-title":"NS1 protein as a novel anti-influenza target: map-and-mutate antiviral rationale reveals new putative druggable hot spots with an important role on viral replication","volume":"565","author":"Trigueiro-Louro","year":"2022","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.virol.2022.11.001_bib64","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/prot.10146","article-title":"Scoring residue conservation","volume":"48","author":"Valdar","year":"2002","journal-title":"Proteins Struct. Funct. Genet."},{"issue":"15","key":"10.1016\/j.virol.2022.11.001_bib65","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1093\/bioinformatics\/bts310","article-title":"A web server for automatic binding site prediction, analysis and druggability assessment","volume":"28","author":"Volkamer","year":"2012","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.virol.2022.11.001_bib66","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.tim.2018.12.013","article-title":"Interplay between influenza virus and the host RNA polymerase II transcriptional machinery","volume":"27","author":"Walker","year":"2019","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.virol.2022.11.001_bib67","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2020.05.034","article-title":"Structural basis for RNA replication by the SARS-CoV-2 polymerase","volume":"182","author":"Wang","year":"2020","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.virol.2022.11.001_bib68","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","article-title":"Jalview Version 2-A multiple sequence alignment editor and analysis workbench","volume":"25","author":"Waterhouse","year":"2009","journal-title":"Bioinformatics"},{"issue":"7809","key":"10.1016\/j.virol.2022.11.001_bib69","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"W\u00f6lfel","year":"2020","journal-title":"Nature"},{"issue":"6498","key":"10.1016\/j.virol.2022.11.001_bib70","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1126\/science.abc1560","article-title":"Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir","volume":"368","author":"Yin","year":"2020","journal-title":"Science"},{"issue":"16","key":"10.1016\/j.virol.2022.11.001_bib71","doi-asserted-by":"crossref","first-page":"7976","DOI":"10.1128\/JVI.00415-06","article-title":"Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice","volume":"80","author":"Zamarin","year":"2006","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2022.11.001_bib72","first-page":"212","article-title":"The 2019 novel coronavirus resource","volume":"42","author":"Zhao","year":"2020","journal-title":"Yi chuan = Hered"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268222200191X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268222200191X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:57:47Z","timestamp":1758589067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004268222200191X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":70,"alternative-id":["S004268222200191X"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2022.11.001","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring new antiviral targets for influenza and COVID-19: Mapping promising hot spots in viral RNA polymerases","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2022.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}